medigraphic.com

2022, Number 3

<< Back Next >>

Folia 2022; 16 (3)

Implications of COVID-19 Pandemic on Skin Conditions

Roque PL, González EM, Pérez CL, Iriarte PMA, Almeida GY, Delgado FY

Language: Spanish
References: 19
Page:
PDF size: 290.81 Kb.


ABSTRACT

The primary cutaneous manifestations of SARS-CoV-2 infection are grouped into five dermatological clinical patterns. However, the implications of COVID-19 pandemic in terms of skin conditions also include the worsening of pre-existing skin diseases, as well as the increased incidence of stress-related dermatoses and others related to phycochemical factors. The objective of the paper was to determine the implications of COVID-19 pandemic in skin conditions. A 22-year-old male patient is reported, with seeming healthy personal pathological history, a medical student, who was carrying out active research for respiratory symptoms, as part of the supporting team in the fight against COVID-19. Approximately 8 weeks after the first case of COVID-19 appeared in Cuba, a primary infection of ocular herpes simplex type 1 was diagnosed, with recurrence 15 days later, as well as a single plaque alopecia areata barbae. Stress is interpreted as triggering factor for this dermatoses. Psychology was consulted, treatment was indicated, with resolution of beard lesions and no recurrence of eye lesions for more than eight months. The importance of this case lies in keeping in mind that manu somatic diseases are closely related to mental health ailments, hence the need to see the individual as a biopsychosocial being.


REFERENCES

  1. Candelaria Brito JC. Estrategia intervencionista dirigida a la prevención y control dela COVID-19 en Consolación del Sur. Consolación del Sur. Rev Ciencias Médicas dePinar del Rio. 2020 [acceso 04/04/2022];24(3):4495. Disponible en:https://revcmpinar.sld.cu/index.php/publicaciones/article/view/4495

  2. Arias Molina Y, Herrero Solano Y, Cabrera Hernández Y, Chibás Guyat D, GarcíaMederos Y. Manifestaciones psicológicas frente a la situación epidemiológica causadapor la COVID-19. Rev haban cienc méd. 2020 [acceso 04/04/2022];19(1):3350.Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3350

  3. Candelaria Brito JC, Díaz Cruz SA, Acosta Pérez DM, Labrador Mazón O, RodríguezMéndez A. Estrategia intervencionista dirigida a la prevención y control de la COVID-19. [acceso 04/04/2022]; Disponible en:http://www.cu/index.php/publicaciones/article/view/4495

  4. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard.Ginebra: World Health Organization; 2022 [acceso 08/04/2022]. Disponible en:https://covid19.who.int/

  5. Sitio oficial de gobierno del Ministerio de Salud Pública. Parte de cierre del día 7 deabril a las 12 de la noche. La Habana: Centro Nacional de Información de CienciasMédicas; 2022 [acceso 08/04/2022]. Disponible en: https://salud.msp.gob.cu/parte-decierre-del-día-7-de-abril-a-las-12-de-la-noche-3/

  6. Pérez Abreu MR, Gómez Tejeda JJ, Dieguez Guach RA. Características clínicoepidemiológicasde la COVID-19. Rev haban cienc méd. 2020 [acceso04/04/2022];19(2):3254. Disponible en:http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505

  7. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur AcadDermatol Venereol. 2020 [acceso 04/04/2022];34(5):212. Disponible en:https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16387

  8. Galván Casas C, Catalá A, Carretero Hernández G, Rodríguez-Jiménez P, FernándezNieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations ofCOVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.British Journal of Dermatology. 2020 [acceso 04/04/2022];183(1):71-7. Disponible en:https://onlinelibrary.wiley.com/doi/10.1111/bjd.19163

  9. Almutairi N, Schwartz RA. COVID-19 with dermatologic manifestations andimplications: An unfolding conundrum. Dermatologic Therapy. 2020:135-44. DOI:https://doi.org/10.1111/dth.13544

  10. Hernández-Rodríguez J. Impacto de la COVID-19 sobre la salud mental de laspersonas. Medicentro Electrónica. 2020 [acceso 04/04/2022];24(3):16. Disponible en:http://www.medicentro.sld.cu/index.php/medicentro/article/view/3203

  11. Proenza Fernández L, Gallardo Sánchez Y, Figueredo Remón RJ. Caracterización delcomportamiento académico en estudiantes de medicina frente a la pesquisa de la COVID-19. Multimed. 2020 [acceso 04/04/2022];24(3):599-615. Disponible en:http://www.revmultimed.sld.cu/index.php/mtm/article/view/1949/1954

  12. Pérez Abreu MR, Gómez Tejeda JJ, Tamayo Velázquez O, Iparraguirre Tamayo AE,Besteiro Arjona ED. Alteraciones psicológicas en estudiantes de medicina durante lapesquisa activa de la COVID-19. MEDISAN. 2020 [acceso 04/04/2022];24(4):11.Disponible en: http://www.medisan.sld.cu/index.php/san/article/view/3159

  13. Turan Ç, Metin N, Utlu Z, Öner Ü, Kotan ÖS. Change of the diagnostic distributionin applicants to dermatology after COVID-19 pandemic: What it whispers to us?Dermatologic Therapy. 2020 [acceso 04/04/2022]; 33(4):13804. Disponible en:https://onlinelibrary.wiley.com/doi/full/10.1111/dth.13804

  14. Irarragorri Dorado CA, Masó Semanat E, Rodríguez Alonso Y, del Valle CaballeroDd. Caracterización epidemiológica y clínica de pacientes con infecciones ocularescausadas por herpesvirus. MEDISAN. 2020 [acceso 04/04/2022];24(1):14. Disponibleen: http://www.medisan.sld.cu/index.php/san/article/view/2593

  15. González Pérez Y, Falcón Lincheta L. Calidad de vida pre y postratamiento enpacientes con herpes simple. Folia Dermatológica Cubana. 2018 [acceso04/04/2022];12(1):113. Disponible en:http://www.revfdc.sld.cu/index.php/fdc/article/view/113/94

  16. Sánchez Segura M, González García RM, Cos Padrón Y, Macías Abraham C. Estrésy sistema inmune. Rev Cubana Hematol Inmunol Hemoter. 2007 [acceso04/04/2022];23(2). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892007000200001&lng=es

  17. Metola Gómez M, Camacho Pastor MA, Dones Carvajal JJ, Martín Blázquez M.Alopecia areata: ¿desencadenante el estrés? SEMERGEN. 2004; 30(2):87-9.

  18. González-Hernández WC, Méndez-Juárez A, Sánchez-Álvarez I. Tratamientosemergentes de la alopecia areata. Dermatol Rev Mex. 2019 [acceso04/04/2022];63(5):469-80. Disponible en:https://www.medigraphic.com/pdfs/derrevmex/rmd-2019/rmd195f.pdf

  19. Morales-Miranda AY, Bueno-Arias GM, Aguirre-Félix OG, Tovar-Franco R.Tratamiento con tofacitinib en adolescentes con alopecia areata. Bol Med Hosp InfantMex. 2019 [acceso 04/04/2022];76:182-7. Disponible en:https://www.medigraphic.com/pdfs/bmhim/hi-2019/hi194d.pdf




2020     |     www.medigraphic.com